发明名称 |
SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS |
摘要 |
<p>This invention relates to novel 2,3-dihydroimidazo[1,2-c]quinazoline compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for phosphotidylinositol-3-kinase (PI3K) inhibition and treating diseases associated with phosphotidylinositol-3-kinase (PI3K) activity, in particular treating hyper-proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients.</p> |
申请公布号 |
EP2096919(A1) |
申请公布日期 |
2009.09.09 |
申请号 |
EP20070862580 |
申请日期 |
2007.12.05 |
申请人 |
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT |
发明人 |
HENTEMANN, MARTIN;WOOD, JILL;SCOTT, WILLIAM;MICHELS, MARTIN;CAMPBELL, ANN-MARIE;BULLION, ANN-MARIE;ROWLEY, R. BRUCE;REDMAN, ANIKO |
分类号 |
C07D487/04;A61K31/519;A61K31/5377 |
主分类号 |
C07D487/04 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|